VOZOL Unveils UK Debut of Open-Pod Ace Max with 'Largest HD Touch Screen'

Market by 2FIRSTS.ai
Dec.13.2024
VOZOL Unveils UK Debut of Open-Pod Ace Max with 'Largest HD Touch Screen'
VOZOL introduces new open system e-cigarette, Ace Max, featuring world's largest HD touch screen, now available in UK.

Special announcement:

This article is intended for internal industry communication only and does not make any recommendations for brands or products.

The images presented in this article are used solely to depict factual information and are not intended as advertisements for any products.

This article prohibits access for minors.


Recently, it has come to the attention of 2Firsts that the well-known e-cigarette brand VOZOL has launched a new open system, the VOZOL Ace Max, on its official website. The brand's promotion claims that this product features "the world's largest high-definition touch screen." Currently, the VOZOL Ace Max is available on the websites of e-cigarette distributors in the UK, such as vapesuperstore and ideavape.

 

VOZOL official website showcases its first open system product

 

VOZOL Unveils UK Debut of Open-Pod Ace Max with 'Largest HD Touch Screen'
VOZOL Ace Max | Image Source: VOZOL Official Website

 

Specifically, the product features of VOZOL Ace Max are as follows:

 

VOZOL Unveils UK Debut of Open-Pod Ace Max with 'Largest HD Touch Screen'
VOZOL Ace Max product specifications | Graphic: 2Firsts

 

According to the information posted on the official website of the VOZOL brand, VOZOL Ace Max is the only open system product showcased by the brand. It belongs to the "ACE" product series and its main feature is the 1.47-inch touch screen display, which shows data including power, inhalation count, and battery level.

 

The only e-liquid product displayed on the VOZOL official website

 

On the official website for VOZOL Ace Max, the "Product Recommendations" section displays an e-liquid product available in two nicotine concentrations, 20mg and 50mg, and two sizes, 10ml and 30ml. The brand also offers a variety of 60 different flavors for consumers to choose from.

 

VOZOL Unveils UK Debut of Open-Pod Ace Max with 'Largest HD Touch Screen'
VOZOL E-liquid | Image source: VOZOL official website

 

This e-liquid is currently the only e-liquid product displayed on the official website of the VOZOL brand.

 

It is reported that VOZOL Ace Max was officially launched on the official website of VOZOL in November this year. Currently, the product is available on e-cigarette distributor websites such as vapesuperstore and ideavape in the UK, with a selling price of around £29.99.

 

VOZOL Unveils UK Debut of Open-Pod Ace Max with 'Largest HD Touch Screen'
VOZOL Ace Max real picture | Image source: ideavape

 

2Firsts discovered through online e-cigarette retailers such as vapesourcing, vapeclub, zerovapes, that the VOZOL brand mainly sells disposable e-cigarettes and a few pod systems. As of the time of writing, there have been no other open system products from the VOZOL brand except for the VOZOL Ace Max.

 

2Firsts will continue to monitor the performance and market trends of e-cigarette products globally, providing the public with accurate and authoritative industry information.

 


The product section focuses on providing readers with the latest information in the tobacco industry, welcoming submissions from readers to share the newest products in the e-cigarette field.

 

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

As JUUL2 Wins FDA Authorization, Harm Reduction Journal Highlights the Role of Real-World Evidence in Nicotine Product Regulation
As JUUL2 Wins FDA Authorization, Harm Reduction Journal Highlights the Role of Real-World Evidence in Nicotine Product Regulation
A commentary published in the international open-access, peer-reviewed Harm Reduction Journal argues that randomized controlled trials remain central to evaluating smoking cessation efficacy but cannot alone capture real-world uptake, complete switching, longer-term use and population impact of non-combustible nicotine products such as e-cigarettes, heated tobacco and nicotine pouches. The authors frame impact as “reach × efficacy” and call for real-world evidence to complement RCTs. Three days after publication, the FDA authorized three JUUL2 products and highlighted complete switching among adult smokers in explaining its decision, providing a timely regulatory backdrop to the debate.
Sep.08
FDA Authorizes Four More Nicotine Pouches as Review Pilot Expands Beyond Initial Decisions
FDA Authorizes Four More Nicotine Pouches as Review Pilot Expands Beyond Initial Decisions
The FDA has authorized four additional on! nicotine pouches, bringing the U.S. total to 30. The decision marks another outcome of the agency’s nicotine pouch review pilot, whose communication and review practices are now being applied more broadly across the category. It also extends Helix’s authorized portfolio from on! PLUS to the earlier on! line. Yet all FDA-authorized nicotine pouches still come from subsidiaries of PMI or Altria, underscoring how concentrated U.S. regulatory access remains.
Aug.05
Special Report | Altria Subsidiaries Sue FDA to Vacate 2021 PMTA Rule as Agency Moves to Speed Reviews
Special Report | Altria Subsidiaries Sue FDA to Vacate 2021 PMTA Rule as Agency Moves to Speed Reviews
2Firsts reviewed the original federal court complaint filed by Altria subsidiaries Helix Innovations and NJOY on Sept. 2 challenging FDA’s 2021 PMTA rule. The lawsuit questions whether FDA’s review process complies with the Tobacco Control Act’s 180-day timeline, even as the agency moves to accelerate PMTA reviews and issues more marketing orders. Drawing on the complaint, FDA records, government audits and recent court rulings, 2Firsts examines the legal arguments, supporting evidence and potential implications for the U.S. tobacco review system.
Regulations
Sep.03
China Discloses First Criminal Case Over Counterfeit Vapes Disguised as “Medical Nebulizers” and “Zero-Nicotine” Products
China Discloses First Criminal Case Over Counterfeit Vapes Disguised as “Medical Nebulizers” and “Zero-Nicotine” Products
Chinese authorities have disclosed the country’s first reported criminal case involving counterfeit vapes marketed as “medical nebulizers” and “zero-nicotine” products. Authorities determined that the products involved were counterfeit vapes and pursued criminal charges for producing and selling counterfeit goods. According to the report, the case resulted in the seizure of 347,000 counterfeit vape pods and 53,700 vape devices, with physical goods valued at 22.13 million yuan.
Aug.04
Zhang Xiaotang Appointed Deputy Director of China’s Tobacco Regulator, Adding Another Finance-Background Official to Top Leadership
Zhang Xiaotang Appointed Deputy Director of China’s Tobacco Regulator, Adding Another Finance-Background Official to Top Leadership
China’s State Council has appointed Zhang Xiaotang as deputy director of the State Tobacco Monopoly Administration, with the regulator’s official website now listing him as a Party leadership group member and deputy director. Zhang previously led Hebei China Tobacco and earlier headed the STMA’s finance and audit department. His appointment follows the elevation earlier this year of former tax official Yao Laiying to head the STMA, adding another senior official with a strong fiscal or financial-management background to China Tobacco’s top leadership in 2026.
News
Sep.20
Canada Health Minister Says She Is Not Considering Looser Nicotine Pouch Retail Rules as PMI-Linked Group Pushes for Wider Access
Canada Health Minister Says She Is Not Considering Looser Nicotine Pouch Retail Rules as PMI-Linked Group Pushes for Wider Access
Canadian Health Minister Marjorie Michel says she is not considering loosening retail restrictions on nicotine pouches. Canada regulates pouches containing 4 mg or less of nicotine per unit as non-prescription nicotine replacement therapy and requires newer NRT formats such as pouches to be sold from behind pharmacy counters. Meanwhile, Unsmoke Canada, linked to Philip Morris International's Canadian business, is pushing to allow pouches in convenience stores and other general retail outlets. Health Canada also acknowledges continued unauthorized sales, while recent research shows rising pouch use among Canadian youth aged 16 to 19.
Sep.24